Encompass Health Corp. Form 8-K Summary
Business Context and Reporting Period
Encompass Health Corporation (EHC) filed this Form 8-K on April 30, 2026, to report financial results for the three months ended March 31, 2026. The filing incorporates a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) regarding the first quarter of 2026. The Company utilizes "same-store" comparisons for performance metrics, which include results from market consolidation and capacity expansions in existing markets.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it defines the non-GAAP measures used to assess performance:
- Adjusted Earnings Per Share: Excludes government settlements, professional fees, mark-to-market adjustments, hedging gains/losses, debt extinguishment losses, tax provision adjustments, and restructuring items.
- Leverage Ratio: Defined as consolidated total debt to Adjusted EBITDA for the trailing four quarters. The credit agreement allows cash on hand to be deducted from total debt.
- Adjusted EBITDA: Used as a liquidity measure and a key component of credit agreement covenants. It adds back interest, taxes, depreciation, amortization, and specific non-recurring items (capped at $10 million for cash expenditures) to net income.
- Adjusted Free Cash Flow: Defined as net cash from operating activities minus maintenance capital expenditures, distributions to noncontrolling interests, and non-indicative items. Common stock dividends are excluded.
Material Changes and Comparisons
The filing does not disclose specific quantitative changes versus the prior comparable period. It notes that "same-store" comparisons are used to explain changes in performance metrics, incorporating the financial results of market consolidation transactions and capacity expansions. The text states that the impact of these transactions on results of operations is difficult to determine with precision.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding future events, business strategy, growth targets, labor cost trends, and financial plans. Key risks and contingencies include:
- Covenant Compliance: Noncompliance with interest coverage or leverage ratio covenants could trigger immediate repayment of all borrowed amounts, prohibit dividends, and restrict asset acquisitions or dispositions.
- Non-GAAP Limitations: Adjusted EBITDA and Adjusted Free Cash Flow are not GAAP measures and may not be comparable to other companies. They exclude significant components of financial performance.
- Uncertainty: Actual results may differ materially from estimates due to risks beyond the Company's control, including legislative or regulatory impacts.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) and Exhibit 99.2 (Supplemental Information) for specific GAAP and non-GAAP financial figures for Q1 2026.
- Verify the reconciliation of Adjusted EBITDA to net income and net cash provided by operating activities to understand the magnitude of excluded items.
- Confirm the Company's current leverage ratio and interest coverage ratio against credit agreement covenants to assess liquidity risk.
- Examine the "same-store" calculation methodology to understand the impact of recent market consolidations and capacity expansions on reported growth.
- Check the upcoming Form 10-Q for the quarter ended March 31, 2026, for detailed GAAP financial statements and cash flow data.